DOI: http://dx.doi.org/10.18203/2319-2003.ijbcp20180660

A prospective, double blind randomised controlled trial on efficacy of laparoscopic uterosacral nerve ablation as an alternative of pharmacotherapy in treatment of chronic pelvic pain

Beenu Kushwah, Devendra Singh Kushwah, Aparna Pandey

Abstract


Background: Chronic Pelvic Pain (CPP) is one of the commonest symptomatology in gynaecologist’s outpatient clinics. CPP has a profound impact on a woman's health and quality of life, including an economic impact through loss of working hours. Treatment for chronic pelvic pain is often unsatisfactory. Present study compares Laparoscopic Uterosacral Nerve Ablation (LUNA) with laparoscopy without pelvic denervation in patients presenting with chronic pelvic pain to our outpatient clinic.

Methods: It was a Randomised Controlled Trial Study. After considering inclusion and exclusion criteria, 120 patients were selected, out of which 60 (Group I) had undergone diagnostic laparoscopy and 60 (Group II) had undergone diagnostic laparoscopy with LUNA.

Results: The overall success rate for group I and group II were 80%, 78.3% and 66.6% versus 85%, 81.6%, and 83.3% at 3, 6, and 12 months, respectively. However, on subgroup analysis it was found that in patients suffering from Congestive Dysmenorrhoea, there was a significant difference in success rate of both the groups.

Conclusions: It was found in present study that there was a benefit for patients with dysmenorrheal, further research in this area is desirable to reach towards a discrete conclusion regarding the benefits of LUNA in patients of CPP.


Keywords


Chronic pelvic pain, CPP, Dysmenorrhoea, Diagnostic laproscopy, Laproscopic uterosacral nerve ablation, LUNA

Full Text:

PDF

References


Shin JH, Howard FM; Management of chronic pelvic pain: Curr Pain Headache Rep. 2011 Oct;15(5):377-85.

Ahangari A. Prevalence of Chronic Pelvic Pain Among Women: An Updated Review. Pain Physician. 2014;17:E141-E147.

Yosef A, Ahmed A, Hussaini A, Abdellah M, Cua G. Chronic pelvic pain: Pathogenesis and validated assessment. Middle East Fertility Society Journal, Dec 2016;21(4):205-21.

Royal College of Obstetricians and Gynaecologists. The initial management of chronic pelvic pain. Green-top Guideline No. 41 May 2012.

Proctor ML, Latthe PM, Farquhar CM, Khan KS, Johnson NP. Surgical interruption of pelvic nerve pathways for primary and secondary dysmenorrhea Cochrane Database of Systematic Reviews. The Cochrane Collaboration; 2007 Issue 3.

Daniels J, Gray R, Hills RK, Latthe P, Buckley L, Gupta J, et al. LUNA Trial Collaboration Laparoscopic uterosacral nerve ablation for alleviating chronic pelvic pain: a randomized controlled trial. JAMA. 2009 Sep 2;302(9):955-61.

National Institute for Clinical Excellence (NICE). Laparoscopic uterine nerve ablation (LUNA) for chronic pelvic pain. IP Guidance Number: IPG234. London, UK: NICE; October 2007 Available at: http://www.nice.org.uk/nicemedia/pdf/IPG234Guidance.pdf. Accessed February 28, 2015.

Palomba S, Russo T, Falbo A. Laparoscopic uterine nerve ablation versus vaginal uterosacral ligament resection in postmenopausal women with intractable midline chronic pelvic pain: a randomized study. Eur J Obstet Gynaecol. 2006;129:84-91.

Xiong T, Daniels J, Middleton L, Champaneria R, Khan KS, Gray R, et al. International LUNA IPD Meta-analysis Collaborative Group: meta-analysis using individual patient data from randomised trials to assess the effectiveness of laparoscopic uterosacral nerve ablation in the treatment of chronic pelvic pain: a proposed protocol. BJOG. 2007 Dec;114(12):1580e1-7.

Dunselman GAJ, Vermeulen N, Becker C. ESHRE guideline: management of women with endometriosis. Hum Reprod. 2014;29:400e12.